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Summary 
Programmed cell death plays an important role during thymocyte development, since a vast majority 
(97%) of mouse cortical thymocytes die in thymus, whereas only 3% of these cells are rescued 
from cell death and positively selected. Although it seems well established that thymocyte fate 
depends upon appropriate surface-expressed T cell receptor, little is known about the molecular 
mechanism(s) responsible for the massive thymocyte elimination that occurs in the thymus. We 
report here that Thy-1 is capable of triggering mouse thymocyte death in vitro through a bcl- 
2-resistant mechanism. We have previously shown that Thy-1 is involved in mouse thymocyte 
adhesion to thymic stroma through interaction with an epithelial cell ligand. To examine the 
Thy-1 signaling function in thymocytes, we have mimicked its interaction with stromal cells 
by culturing mouse thymocytes onto tissue culture plates coated with monoclonal antibodies 
(mAb) directed at distinct Thy-1 epitope regions, mAb recognizing determinants in a defined 
Thy-1  structural domain, but not others, were found to induce marked thymocyte apoptosis 
as evidenced by morphological and biochemical data. Use of a quantitative DNA dot blot assay 
indicated that Thy-l-mediated thymocyte apoptosis was not blocked by RNA or protein synthesis 
inhibitors, EGTA, or by cyclosporin A, and differed, therefore, from "activation-driven cell death". 
Moreover, Thy-1 +-transfected, but not wild-type AKP,1 (Thy-1-d) thymoma cells underwent 
apoptosis after ligation with apoptosis-inducing, Thy-l-specific mAb. In contrast to thymocytes, 
the latter event was inhibitable by KNA  and protein synthesis inhibitors,  an indication that 
thymocytes, but not thymoma cells, contain the molecular components necessary for Thy-l-driven 
apoptosis. We further showed that Thy-l-triggered thymocyte death is a developmentally regulated 
process operative in fetal thymocytes from day 17 of gestation, but not in peripheral T  cells. 
Indeed, the target of apoptosis by anti-Thy-1 was found to reside mainly within the CD4§247 - 
and CD4+8+3 l~ double positive immature thymocyte subsets. Finally, it is of major interest that 
Thy-l-mediated apoptosis, which was found to be readily detectable in thymocytes from bcl- 
2-transgenic mice, represents a thus far unique experimental system for studying bcl-2-resistant 
thymocyte death mechanism(s). 
C 
ell division and death regulate the generation of appro- 
priate numbers and types of cells during development 
and maintain cellular homeostasis in adult animals, This nat- 
uraUy occurring cell death, which is referred to as programmed 
cell death (PCD) t (1, 2) depends upon both genetic and en- 
vironmental factors (3) and usually occurs by apoptosis, a mor- 
phologically defined process including loss of cell volume, 
membrane blebbing, shrinkage and breakdown of nuclei (4), 
1 Abbreviations used in this paper: ADCD, activation-driven cell death; 
DEX, dexamethasone;  DP, double-positive;  Fd, fetal day; GPI, glycosyl- 
phosphatidylinositol;  HSA, heat-stable antigen; PCD, programmed cell 
death; SP, single-positive. 
and in many cases internucleosomal fragmentation of chro- 
matin (5). 
PCD is pivotal in thymic ontogeny. During T  cell devel- 
opment, thymocyte precursors enter the thymus and mature 
in the vicinity of thymic stroma (6, 7). Before reaching the 
fully  differentiated  CD4 §  or  CD8 §  single-positive  (SP) 
phenotype, immature thymocytes undergo massive cell ex- 
pansion (during which they rearrange their gene segments 
coding for the TCIL) and stringent selection processes (8-10). 
Experimental evidence indicates that thymocytes recognizing 
self-antigen/MHC  complexes or surface TCR-negative or 
-ignored thymocytes are eliminated (6,  11-14) by apoptosis 
(15, 16). In contrast, thymocytes recognizing self-MHC mol- 
ecules are rescued from PCD (12,  17).  Only 3% of cortical 
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whereas the great majority of thymocytes (97%) die in the 
thymus  (6,  13). 
In addition to thymocyte apoptosis depending upon the 
state of TCR engagement, defined external signals have been 
shown to promote thymocyte PCD. Thus, CD3-specific mAb 
can induce thymocyte apoptosis both in vivo (18) and in fetal 
thymic organ culture (19).  Glucocorticoid-induced thymo- 
cyte death represents a classical  model of apoptosis (14).  It 
has been shown recently that  mouse thymocytes could be 
killed by cytolytic T cells through a Fas/APOl-mediated mech- 
anism (20).  Several environmental  signals appear,  therefore, 
capable of triggering thymocyte apoptosis. However, the bio- 
logical significance of these different thymocyte death pathways 
remains to be explored.  It has been proposed that CD3-induced 
apoptosis could mimic the negative selection of autoreactive 
thyrnocytes (18, 19), whereas glucocorticoid-induced cell death 
is reminiscent  of the elimination  of nonselected immature 
thymocytes (14). Recent studies on the bcl-2 protooncogene 
are of particular interest in this context. Originally isolated 
from the breakpoint  of t(14;18)  in human  B cell follicular 
lymphoma cells, bcl-2 encodes a protein that is located at the 
nuclear envelope,  endoplasmic reticulum,  and inner  mem- 
brane of mitochondria (21, 22). Experiments using bc/-2-trans- 
fected cell lines and bcl-2-transgenic  mice have shown that 
bcl-2 behaves as a repressor of PCD in different tissues (2). 
In transgenic mice overexpressing bcI-2 in the thymus, thymo- 
cytes become resistant to apoptosis induced by various stimuli 
such as anti-CD3 mAb, glucocorticoids, PMA, or radiation 
(23, 24).  It is of marked interest that in such mice, no ob- 
vious alteration of either thymocyte homeostasis or negative 
selection has been observed (23, 24), an indication that bcl- 
2-resistant  PCD  mechanisms  can  be  operative  in  these 
processes. In  the same context,  Nakayama et aL  (25) have 
recently reported that Bcl-2 was dispensable for lymphocyte 
maturation. 
Thy-1 is a surface glycoprotein of the Ig superfamily en- 
coded by a well conserved gene (26, 27).  This molecule is 
expressed in brain and hemopoietic stem cells of mammals 
(28, 29). It is also highly expressed in rodent thymocytes and 
used as a differentiation  marker  for mouse T  lymphocytes 
(30). Several members of the Ig superfamily play important 
roles in cell-cell and cell-matrix recognition/adhesion processes 
(26), and their specific interactions with appropriate ligands 
have been shown to initiate signal transduction into cells (31). 
Thy-1 is anchored into the plasma membrane by a glycosyl- 
phosphatidylinositol (GPI) tail (27). GPl-linked proteins are 
known to interact with membrane lipids in a special way and 
to participate in microdomains likely related to morphologi- 
cally defined structures,  caveolae  (32).  Protein  tyrosine ki- 
nases  of the src family (p56 t~, p60f~", and p551r  ") have been 
reported to be associated with these microdomains  and to 
be coimmunoprecipitable  with  Thy-1  (33).  Association of 
Thy-1 with the CD45 protein tyrosine phosphatase has also 
been detected (34).  These findings  make Thy-1,  and more 
generally GPI-linked molecules, good candidates as signal- 
transducing molecules. Accordingly, Thy-l-specific mAb (35, 
36), as well as mAb directed at other GPI-linked molecules 
(33), have been reported to be mitogenic for mature T cells. 
Thy-1 surface expression peaks (~106 molecules per cell) 
at the CD4 +8 + double-positive (DP) stage of thymocyte de- 
velopment (27, 37). This expression is downregulated in ma- 
ture SP thymocytes and in peripheral T cells (38). Mitogenic 
Thy-l-specific mAb can activate mouse SP TCR-ot//3  and 
TCR-y/8  thymocyte subsets to proliferate  (39,  40).  Little 
is known, however, about the possible function of Thy-1 in 
immature  thymocytes which represent 80-90%  of thymo- 
cytes. We have recently shown that Thy-1 is capable of medi- 
ating mouse thymocyte adhesion to thymic stromal cells (41, 
42). We report here that immobilized mAb, directed at de- 
terminants  in a defined Thy-1 epitope region,  assayed in an 
experimental system mimicking such a cellular interaction, 
can  promote  marked  apoptosis in  cultured  immature  DP 
thymocytes. This cell death pathway is developmentally regu- 
lated  and occurs through  a bcl-2-resistant  mechanism. 
Materials and Methods 
Materials and Reagents.  Swiss  mice were maintained in our an- 
imal facilities and used at the age of 4-6 wk. Timed-pregnant Swiss 
mice were from Iffa-Credo (Les Ullis, France). El~-bcl-2 strain 36 
transgenic mice were kindly donated by A. W. Harris (Waker and 
Eliza Hall Institute  of Medical Research, Victoria, Australia). All 
reagents were from Sigma (Saint-Quentin-Fallavier, France), ex- 
cept Trypsin-EDTA (GIBCO-BRL, Cergy-Pontoise, France) and 
Dynabeads M-450 sheep anti-rat  IgG (Biosys S.A., Compi~gne, 
France). Dexamethasone (DEX) and PMA were prepared as 1 mM 
stock solutions in 95% ethanol  and kept at  -20~  Cyclohexi- 
mide and actinomycin D were prepared as 1 mM or 1 mg/ml stock 
solutions in H20, respectively, and kept at 4~ 
Cells.  AKR1  (Thy-l-d)  thymoma  cells and  the  derivative 
TFX435 Thy-l.1 + transfected cells were kindly provided by R. 
Hyman (The Salk Institute, San Diego, CA). All cells were grown 
in DMEM supplemented with 1 mM sodium pyruvate and 5% 
FCS in a humidified 10% CO2 atmosphere, except as otherwise 
indicated. Single thymocyte suspensions were prepared by teasing 
thymuses in culture medium (DMEM plus 10% FCS). Spontaneous 
thymocyte apoptosis, as measured by DNA fragmentation  at the 
end of the culture period (24 h), was comprised between 5 and 
10%. T cell-enriched splenocytes were obtained by the nylon-wool 
method. 
mAh  The main characteristics of the mAb used in this study 
are listed in Table 1. Both the KT16 and G7 mAb were kindly 
donated by M. Millrain (Clinical Research Centre, Harrow, UK). 
mAb were purified from ascitic fluids and stored in PBS at -20~ 
mAb coating of microtiter plates (37~  overnight) was performed 
at a concentration of 25/zg/ml in PBS, unless otherwise indicated. 
The wells were washed twice with DMEM and once with com- 
plete culture  medium before use. 
Cortisone Treatment.  5-wk-old  mice were  injected  intraperi- 
toneally with 2.5 mg/mice of hydrocortisone acetate (Roussel, Paris, 
France) at 48 and 24 h before the experiment  day. 
DNA Dot Blot Assay for Measuring Cell Death-associated DNA 
Fragmentation.  This original DNA fragmentation assay, which will 
be detailed elsewhere (Hueber, A.-O.,  M. Pierres, and H.-T.  He, 
manuscript in preparation) has been adapted from those previously 
described (43, 44). The assay relies on the fact that fiberglass can 
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DNA fragments from apoptotic cells (43) or RNA. Briefly, at the 
end of the culture,  ceils were harvested onto fiberglass  filters by 
vacuum aspiration. After extensive washings, the filters  were se- 
quentially incubated in ethanol and in 3X SSC, 0.1% SDS for 30 
min, respectively,  and saturated for another 30-min period in 5X 
Denhart's solution diluted in 89 mM Tris, 89 mM boric acid, and 
2 mM EDTA, pH 8.4. The filters were stained with ethidium bro- 
mide (5/~g/ml in the same solution) for 15 rain and washed fur- 
ther with ethanol to eliminate nonspecific binding. Fluorescent filters 
were  photographed  and  digitized  by The  Imager  |  (Appligene, 
IUkirch, France). The quantitation of digitized spots was made using 
the NIH image version 1.42 software system. Percent fluorescence 
was defined as 100 x  the fluorescence intensity ratio between treated 
and untreated cells.  The values  were expressed as the means (+ 
SE) of four to six identical assays. 
Agarose Get Electrophoresis of DNA.  Cultured  thymocytes in 
microtiter plates were centrifuged for 10 rain at 1,200g. Cell pellets 
were mixed with 30/xl of 10 mM EDTA, 50 mM Tris-HC1,  pH 
8.0, 0.5% sodium lauryl sarkosinate buffer, and samples were in- 
cubated for 1 h at 50~  RNase A (10/ll of a 0.5 #g/ml solution) 
was added and samples  were incubated further for 1 h  at 50~ 
The temperature was increased to 70~  before adding 10 #1 of 10 
mM EDTA, pH 8.0, 1% low-melting temperature agarose, 0.25% 
bromophenol blue, and 40% sucrose. Samples (20 #1) were loaded 
into wells of a 1.5% agarose gel and run at 10 V overnight in 89 
mM Tris, 89 mM boric acid, and 2 mM EDTA, pH 8.4. Ethidium 
bromide (0.5/zg/ml) was added to the gel before electrophoresis. 
DNA was visualized and photographed by The Imager  | 
Electron Microscopy.  Thymocytes  (106), cultured  in  24-well 
plates,  were centrifuged at  1,200 g  for 10 min and the medium 
was replaced by Trypsin-EDTA for 15 min at 37~  The culture 
plates were assembled with empty plates, turned upside down, and 
centrifuged at 2,000g for 15 min at 4~  The solution of Trypsin- 
EDTA was discarded  and replaced by cold PBS. Thymocytes were 
then transferred in Eppendorf tubes and centrifuged at 2,000 g for 
15 rain at 4~  Pelleted  cells were fixed with 2% glutaraldehyde 
in 0.2 M sodium cacodylate buffer (pH 7.4) at 4~  for 2 h. After 
several washes in the same buffer, cell pellets were postfixed with 
2% OsO4 in the same buffer for 45 rain,  and dehydrated in 30, 
50, 70, 95, and 100% ethanol, followed by two incubations  in 100% 
propylene oxide for 10 rain.  Specimens were embedded in epon 
812 according to standard procedures. Ultra-thin sections were cut 
with an ultramicrotome (LKB-Ultratome III, Bromma, Sweden) 
and examined on an electron microscope (model H-600; Hitachi 
Ltd., Tokyo, Japan) after counterstaining with uranyl acetate and 
lead citrate. 
Immunomagnetic Cell Depletion.  Thymocytes from day 18 fetal 
mice were incubated with CD3-specific mAb KT3 diluted in cul- 
ture medium for 30 min at 4~  After washes, the Dynabeads sheep 
anti-rat IgG was added to the cell suspension,  and the mixture 
was rotated for 30 rain at 4~  Thymocytes with attached beads 
were then removed, using a Dynal Magnetic Particle Concentrator 
(Biosys S.A.,  Compi~gne,  France). 
Results 
Immobilized  Thy-l-specific mAb Induce Mouse  Thymocyte 
Apoptosis.  As an approach to analyze Thy-l-mediated sig- 
naling, mouse thymocytes were cultured in microtiter plates 
coated with  mAb directed at different Thy-1 determinants 
(36, 45). It was observed that more than 50% of the thymo- 
Table  1.  mAbs  Used in this Study 
mAb  Specificity  IgH isotype  Reference 
KT16  Thy-lA*  rat  IgG2c  45 
G7  Thy-lA  rat  IgG2~  45 
H194-539  Thy-lA  rat  lgM  58 
H129-93  Thy-l.2A  rat  IgG2~  36 
H140-150  Thy-lB  rat  lgG2b  36 
H154-177  Thy-lC  rat  IgG2b  36 
H154-200  Thy-lC  rat  IgG2b  36 
H155-124  Thy-lC  rat  IgG2b  36 
145.2Cll  CD3  hamster IgG  59 
KT3  CD3  rat  IgG2~  60 
H129-19  CD4  rat  IgG2,  61 
H35-17  CD8  rat  IgG2b  62 
H194-112  CD26  rat  IgGza  63 
H193-16  CD45  rat  IgG2,  42 
H35-89  LFA-lot  (CDlla)  rat  IgG2b  62 
H194-563  HSA  rat  IgG2b  64 
49-h4.3  ThB  rat  IgG~  65 
* Specificity for Thy-1 epitope regions (A, B, and C). 
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plates  displayed  specific  morphological  changes  including 
reduction of cell volume, condensation of chromatin, and floc- 
culation of the cytoplasm, as visualized by electron micros- 
copy (Fig.  1, a and b). These KT16-induced morphological 
modifications  (Fig.  1 d) were not  observed with  a control 
mAb (Fig.  1 e) and resembled the features of DEX-induced 
apoptotic cell death (4,  and Fig.  l f).  Indeed, cells lost sur- 
face microvilli, displayed membrane blebbing and a nucleus 
condensed into  a uniform  mass located at  one edge of the 
cell.  Several  stages of Thy-l-mediated  apoptosis  occurring 
in a same culture are shown in Fig.  1, g-j.  Enhanced inter- 
nucleosomal DNA  fragmentation  was observed in thymo- 
cytes cultured on Thy-lA-specific mAb KT16,  but not on 
mAb H194-563 or H154-200 (directed at the heat-stable an- 
tigen (HSA) or Thy-lC,  respectively, see Table  1) (Fig.  2). 
Measurement of Tkymocyte Apoptosis by Means of  DNA Dot 
Blot Assay.  We developed a DNA  fragmentation  assay in 
order to quantify apoptosis of nonproliferating  cultured thymo- 
cytes.  This assay took advantage of the observation (43, 44) 
that harvesting cells onto glassfiber filters permitted the sepa- 
ration of intact chromatin (retained on the filter) from DNA 
fragments of apoptotic cells (been washed through).  Indeed, 
quantitation  of apoptosis could be deduced from the mea- 
surement  of DNA on the filter,  a reflection of the number 
of remaining  viable cells  in the culture.  As can be seen  in 
Figure  1.  Electron  microscopic  examination of  Thy-l-mediated  thymocyte  apoptosis.  Thymocytes  cultured  in the absence  (a) or presence  (b) of  plastic-bound 
Thy-l-specific  mAb KT16, for 24 h at 37~  Thymocyte  morphology  in control culture (c); in the presence  of KT16 (Thy-l-specific  mAb) (d); H194-563 
(HSA-specific  mAb) (e); or after treatment with DEX (f). (g-j) Different stages of Thy-l-mediated apoptosis including that induced by KT16 mAb 
(g, i, and j) and by H194-539 mAb, an IgM recognizing like the KT16 Thy-lA epitope region (h). Bar (a and b) 1.14 #m; (c-f) 1.2 #m; (g and h) 
1/~m; (i and./') 1.2/zm. 
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fluorescent  staining  and  the number  of living  thymocytes. 
Use of this DNA dot blot assay revealed, in accordance with 
previous studies,  that DEX (10-7 M) induced  specific death 
of most thymocytes (>80%) after 24 h of culture.  Moreover, 
immobilized mAb KT16 but not a control HSA-specific mAb 
triggered  apoptosis  of more than  50%  thymocytes  (Fig.  3 
B). The dose-response curve of thymocyte apoptosis on plates 
coated with increasing amounts of mAb KT16 (Fig. 4) indi- 
cated that Thy-l-mediated death was maximal at a coating 
concentration  of 10/~g/ml. 
Apoptosis  Is Induced  by mAb Directed at Determinants  in a 
Defined Thy-1 Structural Domain.  To ascertain the specificity 
of thymocyte apoptosis induction  by KT16 mAb, we tested 
several Thy-l-specific mAb (all of the IgG isotype) directed 
at determinants  in  spatially distinct  Thy-1  epitope regions 
(i.e., A, B, and C) (Table 1). After 24 h of culture, thymocyte 
apoptosis, as measured by DNA fragmentation,  was assayed 
as described above. It was observed that Thy-lB (H140-150)- 
and Thy-lC (H154-177,  H154-200,  and H155-124)-reactive 
Figure  2.  Interchromosomal DNA fragmentation of thymocytes upon 
culture on plastic-immobilized KT16 mAb. Thymocytes (105) were cul- 
tured in the presence or absence of mAb for 24 h at 37~  Cell lysates 
were prepared as described in Materials and Methods. Fragmented DNA 
and intact chromatin were resolved on a 1.5% agarose gel and stained 
with ethidium bromide. Lanes (-) Untreated cells; (KT/6) cells incubated 
with KT16 mAb; (HSA) cells incubated with HSA-specific  mAb H194- 
563; (1-1154-200)  cells incubated with H154-200 mAb directed at a Thy-1 
determinant distinct from that recognized by KT16 mAb; and (M) molec- 
ular weight  markers. 
Figure  3.  Thy-l-mediated  thymocyte apoptosis as measured by DNA dot blot assay. (A) The linear relationship between the number of living cells 
harvested and DNA staining on the filter. Increasing amounts of freshly collected thymocytes were distributed in microtiter plates and analyzed as 
described in Materials and Methods. Fluorescent intensity (arbitrary units) of the filter spots (inset)  was measured  by the NIH image version 1.42 software 
program. (B) Thymocyte apoptosis quantified by the reduction of living cell number (i.e., DNA staining) at the end of culture. Thymocytes (1.5  x 
105) from 4-6-wk-old  Swiss mice were cultured in DMEM supplemented with 10% FCS, in the absence (lane C) or presence of immobilized mAb 
(coating concentration,  25/xg/ml) KT16, H194-563 (anti-HSA), or DEX (10 -7 M). After 24 h at 37~  thymocytes were analyzed by DNA dot 
blot assay as in A. In lanes 1/2C and 1/4C, 7.5  x  104 and 3.75  x  104 thymocytes were cultured, respectively. The results were expressed as percent 
fluorescence of untreated cells. 
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Figure 4.  KT16  mAb promotes thymocyte  apoptosis  in a dose-dependent 
manner. KT16 and a control mAb (H194-563, anti-HSA) were coated to 
the plates at increasing concentrations in PBS. Thymocytes (1.5  x  10  s) 
were assayed for apoptosis as described in the legend to Fig. 3 B. The 
results were expressed as percent fluorescence of untreated cells. 
mAb (36) were unable to promote thymocyte apoptosis (even 
on plates  coated  with  100 #g/ml  mAb solution,  data not 
shown),  regardless  of their mitogenic capacity (Fig.  5 A). 
Two mAbs  (KT16  and  G7),  as well as the  IgM H194-539 
(see Fig.  1), all of which recognize Thy-1 epitope region A, 
induced marked thymocyte apoptosis, whereas another mAb 
H129-93 directed at a Thy-1 polymorphic determinant in the 
same epitope region was less efficient in this assay. We also 
tested the effects of several mAb directed at thymocyte sur- 
face proteins,  including  signaling  molecules  such  as CD3, 
CD4,  CDS,  CD26,  and  CD45,  as well as HSA  and  ThB, 
both of which represent abundant GPI-anchored thymocyte 
molecules.  In addition  to KT16,  only one mAb (145.2Cll, 
CD3  specific)  was  found  to induce  thymocyte death  (Fig. 
5 B). However, as already reported (46), the in vitro-induced, 
145.2Cll-mediated  thymocyte death was much lower than 
that obtained in vivo. These observations further confirmed 
the specificity of KT16-inducing apoptosis. It should be em- 
phasized, however, that such results did not rule out the role 
Table  2.  Thy-l-mediated Tkymocyte Apoptosis Is Not Blocked 
by Cycloheximide, Actinomycin D, or EGTA 
Percent  fluorescence* 
Anti-Thy-l* 
Treatmentg  KT16  H154-200  DEXII 
Control  50.4  _+  3.4  85.5  •  2.6  11.6  •  0.8 
Cycloheximide  47.6  _+  2.3  85.7  _  6.2  78.6  _+  5.5 
Actinomycin D  45.8  _+  3.3  98.4  •  5.4  90.0  _+  3.6 
EGTA  49.2  •  6.7  97.7  •  5.3  11.3  _+  4.3 
* Results were expressed as percent fluorescence  (means  from three separate 
experiments  _+ SEM) of untreated cells, in the absence or presence of 
inhibitors,  respectively. 
* mAb coating was performed at a concentration of 25/zg/ml in PBS. 
S Cycloheximide and actinomycin D concentrations were 10/~g/ml  and 
2/~g/ml, respectively. EGTA was added (3.2 mM) in the presence of 
1.8 mM MgClz. No toxic effect was detected in the presence of these 
reagents, at the concentrations indicated. 
11 DEX was added at a final concentration of 10  7 M. 
of these signaling molecules (other than CD3) in thymocyte 
apoptosis. In further experiments, two mAb (KT16 and H154- 
200)  with similar affinity for thymocytes as determined by 
a centrifuge-based adhesion assay (41) (data not shown), were 
used  as  prototypic  apoptosis-inducer  or  control  reagents, 
respectively. 
Thy-l-mediated Apoptosis Is Not Inhibited by RNA  or Pro- 
tein Synthesis Inhibitors and Differs from ADCD  Inhibition 
of macromolecule synthesis has been reported to prevent apop- 
tosis in some cases (3,  14). Data summarized in Table 2 indi- 
cate that the translation inhibitor cycloheximide or the tran- 
scription  inhibitor  actinomycin  D  were  unable  to  modify 
KT16-induced thymocyte apoptosis. In contrast, both com- 
pounds were capable of completely reversing DEX-induced 
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Figure  5.  Thymocyte apoptosis is induced 
by mAb directed at determinants in a defined 
Thy-1 structural domain, mAb-induced  thymo- 
cyte apoptosis was tested as described in the 
legend to Fig. 3 B; see Table I for the charac- 
teristics of the mAb used. (A) mAb directed 
at determinants in a structural domain of Thy-1 
(i.e., epitope region A), but not those directed 
at other Thy-1 domains (i.e., epitope regions 
B and C) were efficient at triggering thymo- 
cyte apoptosis. (B) A variety of mAb specific 
for signaling molecules including CD3, CD4, 
CD8,  CD26,  CD45,  and LFA-1, as well as 
those specific  for other GPI-anchored  molecules 
(e.g., HSA and ThB) were analyzed  for thymo- 
cyte apoptosis induction,  as compared with 
Thy-l-specific mAb KT16. The results were 
expressed as percent fluorescence of untreated 
cells (-). thymocyte death. These observations indicated that macro- 
molecules putatively at play in the Thy-l-dependent apop- 
tosis  pathway were already present before KT16-mediated 
thymocyte triggering. 
Previous studies have shown that mAb directed at GPI- 
anchored molecules, such as Thy-1 and Ly-6, are capable of 
activating mature T  cells to proliferate in a manner similar 
to antigen- or anti-TCIL/CD3 mAb-driven T cell activation 
(33).  The same stimuli have also been found to elicit T hy- 
bridoma or nontransformed T cell death (47, 48). This ADCD 
is of apoptotic nature and can be prevented by RNA and pro- 
tein synthesis inhibitors, and the two compounds EGTA and 
cyclosporin A (47-49).  Interestingly, all these reagents did 
not affect Thy-l-mediated thymocyte death (Table 2, and data 
not shown), which appears, therefore, distinct from ADCD. 
Furthermore,  anti-Thy-1  mAb-induced ADCD  has  been 
reported to be operating in mature, but not in immature T 
cells (48). 
Thy-l-specific mAb Promotes Death of Thy-1 +-transfected 
AKRI  (Thy-1-d) Thymoma Cells which Can Be Blocked by 
RNA  and Protein Synthesis Inhibitors.  We next tested the 
ability of KT16 mAb to elicit death signals in TFX435 cells, 
a  Thy-l.l+-transfectant  of mouse AKR1  (Thy-1-d)  thy- 
moma cells which fail to express  Thy-1, because of a sub- 
chromosomal deletion encompassing the Thy-1 gene (50). 
These AKR1 cells display the DP immature phenotype (data 
not shown). As can be seen in Fig. 6 A, KT16 mAb specifically 
induced apoptosis of 50%  of the TFX435,  but not of the 
wild-type AKR1 (Thy-1 -d)  cells,  after 24 h  of culture in 
the presence of 0.5%  FCS,  during which these cells were 
not dividing.  In contrast to that  observed in thymocytes, 
KT16-induced TFX435  cell death could be completely in- 
hibited by macromolecule synthesis inhibitors (Fig.  6 B). 
Developmental Regulation of Thy-l-mediated Mouse T Cell 
Death.  Since PCD is known to be regulated during devel- 
opment, we next explored whether Thy-l-mediated T cell 
apoptosis could also be developmentally controlled. We first 
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Figure  7.  Mature peripheral T 
cells are refractory to apoptosis in- 
duction by Thy-l-specific mAb. 
T cell-enriched splenocytes (2  x 
105 cells/well) were cultured  for 
48  h  at  37~  in  the presence 
or absence of mAb. DNA of cul- 
tured cells was measured  as de- 
scribed in the legend to Fig. 3 B. 
Thy-l-specific mAb KT16, H154- 
200, and the CD3-specific mAb 
145.2Cll were tested. The results 
were expressed as percent fluores- 
cence of untreated  cells (-). 
tested the effect of immobilized anti-Thy-1 mAb on periph- 
eral T  cells. Nylon wool-enriched splenic T cells were cul- 
tured for 48 h under the conditions described above, and ana- 
lyzed by DNA  dot blot  assay (Fig.  7).  The proliferative 
responses  of these cells  to  CD3-specific mAb  resulted in 
strongly enhanced DNA staining. KT16 mAb promoted a 
very weak cell proliferation (rather than cell death), whereas 
the nonmitogenic, Thy-l-specific mAb H154-200 was de- 
void of any effect. We then examined whether Thy-l-depen- 
dent thymocyte death could be regulated during intrathymic 
T cell development. Fetal and neonatal thymocytes were as- 
sayed for their sensitivity to KT16 mAb. It was observed that 
mouse  thymocytes,  although  refractory to  Thy-1  mAb- 
induced apoptosis up to fetal day (Fd)  16, became sensitive 
to this cell death induction from Fd 17 (Fig. 8). Interestingly, 
DEX-induced thymocyte apoptosis displayed a similar regu- 
lation to that observed with KT16 mAb. 
Thy-1 Triggers  Apoptosis of DP Immature Thymocytes.  To 
further assess the potential physiological role of Thy-l-trig- 
gered apoptosis in T cell development, we carried out experi- 
ments in order to phenotype the target cells for anti-Thy-1- 
induced apoptosis.  It was observed that thymocytes obtained 
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Figure  6.  KT16  mAb  triggers  apoptosis  of transfected 
AKR1 (Thy-1 -d) thymoma cells expressing the Thy-I gene. 
(.4) Thy-l-transfected  (TFX435) and wild-type AKR1 (Thy- 
1 -d) thymoma cells (5  x  104) were cultured in the presence 
of immobilized KT16 mAb or control mAb H154-200 at 37~ 
for 24 h. FCS concentration  in the medium was reduced to 
0.5% to maintain  good viability in nonproliferating  culture 
cells. Cell death was assayed as described in the legend to Fig. 
3 B. The results were expressed as percent fluorescence of un- 
treated TFX435,  or wild-type AKR1 (Thy-1 -d) cells, respec- 
tively. (B) Thy-l-dependent  apoptosis of TFX435 is inhibitable 
by cycloheximide and actinomycin D. Thy-l-triggered apop- 
tosis was tested with KT16 mAb. mAb H154-200 and DEX 
were used as controls.  The inhibitors  were found to be non- 
toxic at the concentrations  used in these experiments  (i.e., 
I and 0.2 #g/ml for cycloheximide and actinomycin D, respec- 
tively). The results were expressed as percent fluorescence of 
untreated  TFX435 cells, cultured in the absence or presence 
of inhibitors,  respectively. 
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Figure 8.  Intrathymic regula- 
tion  of Thy-l-dependent  apop- 
tosis.  Thymocytes  from  Fd  16 
(F16), 17 (FI7), 18 (F18), postnatal 
day 1 (P1),  and adult (ADULT) 
NMR1  mice were collected and 
apoptosis induced by KT16 mAb, 
and  DEX  were  assayed  as  de- 
scribed in the legend to Fig. 3 B. 
mAb H154-200 was used as con- 
trol.  The results  were expressed 
as  percent  fluorescence  of  un- 
treated thymocytes from mice of 
corresponding ages,  respectively. 
from hydrocortisone-treated mice, in which the DP imma- 
ture cells were eliminated, became resistant to KT16-mediated 
cell death (Fig. 9 A). This result indicated that DP, but not 
double negative or SP thymocytes, were the main target for 
Thy-l-dependent apoptosis, an observation consistent with 
the regulation during thymic ontogeny described above. We 
further  evaluated  the  sensitivity  to  apoptosis  of  DP 
CD4+8+3 -  and  CD4+8+31~ thymocyte subsets  by  per- 
forming immunomagnetic separation before cell death assay. 
We favored this experimental design rather than the simul- 
taneous flow cytometry phenotyping techniques after apop- 
tosis induction because thymocyte recovery (without tryp- 
sinization)  from Thy-l-specific mAb-coated plates caused 
substantial cell damage. Depletion from Fd 18 thymocytes 
of the CD4+8 +31~  subset by anti-CD3 mAb, which makes 
up to ~20%  of total  thymocytes at this age (51 and data 
not shown), reduced KT16-mediated  apoptosis from 50 to 
35%  (Fig. 9 B). Altogether, these results, along with the 
observation that Thy-l-triggered apoptosis of Fd 17 thymo- 
cytes in which the DP cells are mainly negative for CD3 sur- 
face expression (51), indicated  that apoptosis induction by 
anti-Thy-1 mAb occurred primarily in both the CD4+8+3 - 
and CD4+8+3 I~ DP thymocyte subsets. 
Thy-1 Triggers Thymocyte Apoptosis through a bct-2-resistant 
Mechanism.  Overexpression of the bcl-2 protooncogene is 
known to protect cells from apoptosis induced by a variety 
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Thy-1 triggers thymocyte apoptosis through a bcl-2-resis-  Figure 10. 
tant mechanism. Thymocytes from bcl-2-transgenic and nontransgenic lit- 
termate mice were assayed for Thy-l-mediated apoptosis (by the KT16 
mAb), as described in the legend to Fig. 3 B. mAb H154-200 were used 
as control. Note the significant protection from PMA-induced cell death 
in bcl-2-transgenic mice. The results were expressed as percent fluores- 
cence of untreated thymocytes from bcl-2-transgenic or nontransgenic lit- 
termate mice, respectively. 
of stimuli (21). In E#-bcl-2 transgenic mice that carry a human 
bcl-2 cDNA under the control of the 5' Igh enhancer and 
overexpressing the transgene within the lymphoid cell com- 
partment, a marked inhibition of thymocyte apoptosis in- 
duced by a series of compounds including CD3-specific mAb, 
glucocorticoids,  or PMA has been observed (24). We ana- 
lyzed, therefore, the Thy-l-mediated thymocyte apoptosis 
in such E#-bcl-2-transgenic mice. Data summarized in Fig. 
10 show that thymocytes from either such transgenic mice 
or their nontransgenic littermates were similarly sensitive to 
apoptosis induction by KT16 mAb. Conversely, in accordance 
with previous results (24), marked survival enhancement was 
detected in thymocytes from E#-bcl-2-transgenic mice after 
PMA treatment since the survival was <1% in normal thymo- 
cytes, but about 40%  in transgenic  thymocytes. 
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Figure  9.  Thy-1 triggers apoptosis of DP im- 
mature thymocytes. (.4) Thymocytes from control 
and hydrocortisone-treated mice were assayed for 
KT16 mAb-induced apoptosis, as described in the 
legend to Fig. 3 B. mAb H154-200 was used as 
control.  The  results  were  expressed  as  percent 
fluorescence of untreated thymocytes. (B) Thymo- 
cytes from day  18 fetal mice were submitted  to 
depletion with Dynabeads coated with or without 
CD3-specific mAb KT3. The remaining cells cor- 
responding  to  CD3-  and  total  thymocytes,  re- 
spectively,  were assayed for KT16-mediated apop- 
tosis,  as described in the legend to Fig. 3 B. mAb 
H154-200 was used as control.  The results were 
expressed  as  percent  fluorescence  of  untreated 
thymocytes. Discussion 
In this study, we aimed at analyzing the signaling events 
in mouse thymocytes resulting from solid-phase  bound mAb- 
mediated Thy-1 ligation.  We have shown that Thy-1 could 
trigger marked thymocyte apoptosis through a bcl-2-resis- 
tant and developmentally regulated mechanism. A similar ex- 
perimental  approach has permitted a functional  analysis of 
CD40-dependent B cell activation (52), before the cDNA 
doning of its ligand (53). Solid phase--bound, neural call adhe- 
sion molecule (NCAM)-specific mAb have also been success- 
fully used to examine the role of NCAM in contact-dependent 
inhibition of fibroblastic cell growth (54). It is of interest 
that in both CD40 and NCAM studies, soluble mAb were 
devoid of signaling effects. In this study, we also found that 
soluble Thy-l-specific mAb could promote only very weak 
thymocyte death (data not shown). This observation  is reminis- 
cent of the failure of soluble anti-Thy-1  rnAb to promote 
significant thymocyte death both in vitro (46) and in fetal 
thymic organ cultures (19). The reason for this difference is 
obscure especially  because soluble Thy-l-specific mAb cross- 
linked by a secondary anti-Ig reagent failed to induce thymo- 
cyte death (data not shown). Indeed, soluble Thy-l-specific 
mAb (in particular those recognizing epitope region A) have 
been reported to induce both Thy-1 clustering  and T  cell 
aggregation,  even in the absence of cross-linker (45). It is 
possible that such aggregation allows additional signaling in 
thymocytes which would alter Thy-l-dependent apoptosis 
induction.  It  is  noteworthy, however,  that  soluble  Thy- 
1-specific mAb have  been shown to potentiate CD3-driven 
thymocyte apoptosis when used as Thy-I-CD3 heterocross- 
linked mAb (46). 
mAb (i.e., KT16,  H194-539, and G7) directed at deter- 
minants in a particular Thy-1 structural domain were found 
to be potent thymocyte apoptosis inducers. These findings 
indicate that the sole interaction of any immobilized mAb 
with Thy-1 is not sufficient, per se, for promoting thymo- 
cyte death, which rather depends on their ability to bind a 
Thy-1 active domain. 
Early  studies  have shown  that  mAb  directed  at  GPI- 
anchored molecules (e.g., Thy-1 and Ly-6) are capable of ac- 
tivating  T  cells to proliferate in a CD3-dependent fashion 
(33). In addition,  the same reagents have been found to in- 
duce ADCD in both transformed T hybridoma and nontrans- 
formed T  cell  lines  (47,  48).  Although ADCD  can  be 
prevented by kNA or the protein synthesis inhibitors, EGTA 
or cyclosporin  A (47-49), we found Thy-l-dependent thymo- 
cyte apoptosis to be insensitive to such compounds.  These 
two types of cell death appear, therefore, unrelated to each 
other,  a notion consistent  with the observation  that Thy- 
1-dependent ADCD is  exclusively observed in mature T 
cells (48). 
An important observation in this study bears on the de- 
velopmental regulation of Thy-l-mediated cell death.  The 
earliest cortical DP thymocytes are detectable at Fd 16 and 
subsequently enter the selection processes (6,  13,  51). The 
nonselected  CD4 +  8 +  3-  and CD4 +  8 +  31~ DP thymocytes, 
which represent the surface TCR-negative and -ignored cell 
populations, respectively,  undergo a 3.5-d end stage (13). Our 
results indicate that Thy-l-triggered fetal thymocyte apop- 
tosis becomes operative at this period and that the main targets 
of this apoptosis reside within both the CD4 +  CD8 §  3- and 
CD4+8+31~ DP thymocyte subsets. It is tempting to specu- 
late, therefore, that Thy-1-mediated apoptosis is involved in 
PCD of the nonselected thymocytes during thymic matura- 
tion. Our ongoing analysis of Thy-1 stromal ligand distri- 
bution in thymus, may give important clues in this respect. 
The molecular mechanism of the intrathymic regulation for 
Thy-l-dependent apoptosis is presently unknown. Indeed, 
the variation of Thy-1 surface expression in thymocytes (i.e., 
very high from day 17, and slightly reduced at day 16 of gesta- 
tion) (37) represents a parameter to be considered in this con- 
text. However, the fact that both DEX- and Thy-l-triggered 
thymocyte apoptosis were similarly regulated during devel- 
opment suggests that other intracellular control events could 
be at play. Later on, in mature T cells, some regulatory mech- 
anisms, distal to the initial signaling events, could repress the 
death program, since such T cells are resistant to Thy-l-, 
CD3-,  or glucocorticoid-induced  apoptosis. 
The removal  by apoptosis of nonselected  DP cortical thymo- 
cytes is likely to be of major physiological importance by 
making, for instance, appropriate room for efficient selection 
processes (14). It is generally assumed that death of such 
thymocytes occurs independently of external stimuli, a con- 
tention supported by the observation that thymocytes die spon- 
taneously ex vivo. However, recent studies on the survival 
gene bcl-2 have challenged this argument. Expression of Bcl-2 
protein can protect cells from PCD in different tissues (2, 
21). In transgenic mice overexpressing bcl-2 in the thymus, 
the life span of thymocytes  in culture is markedly increased. 
T lymphoid cell homeostasis remains however unaffected in 
these transgenic mice, since the whole T cell number as well 
as the major T cell subsets were found to be normal both 
in the thymus and the periphery (23, 24). Although external 
stimuli like anti-CD3 mAb or glucocorticoids are known as 
apoptosis inducers capable of triggering massive thymocyte 
death both in vivo and in vitro (14, 18,  19), their role in 
thymic PCD was also questioned  by the fact that thymo- 
cytes from bcl-2-transgenic  mice resisted efficiently to death 
induced by such factors (23, 24). These findings suggest that 
other cell death pathways can be responsible for the bcl-2-resis- 
tant thymocyte  elimination.  The ability of Thy-1 to trigger 
thymocyte apoptosis in bct-2-transgenic  mice is of interest 
in such a context, and also a strong indication that this apop- 
tosis does not result from an acceleration of the "spontaneous" 
thymocyte death, as bcl-2-transgenic  thymocytes show remark- 
able long life spans in vitro. 
We suggest that several internal  and external death pro- 
gram components are acting to accurately eliminate the large 
number of nonselected thymocytes. Our data showing that 
Thy-l-induced apoptosis proceeds in the absence of new mac- 
romolecule synthesis suggests that immature DP thymocytes 
are programmed to die in response to an external stimulus. 
In contrast, apoptosis induction in AKR1 thymoma cells could 
793  Hueber  et al. depend on the activation of a "suicide gene", a process in- 
hibitable by cycloheximide or actinomycin D. Hence, signaling 
through Thy-1 can also induce cell death in cells that do not 
already contain all the factors required for apoptosis. 
It could be envisioned that Thy-l-triggered apoptosis is 
also involved in the negative selection of self-reactive thymo- 
cytes.  Engagement of CD8 to MHC class I molecules (55, 
56) and LFA-1 to intercellular adhesion molecule 1 (57) have 
been found to cooperate with TCR/CD3 in driving autoreac- 
tive T cell elimination in some experimental systems. Thy-1, 
like CD8 and LFA-1, could hence modulate, through its adhe- 
sive and signaling functions, both the overall affinity of the 
interactions between thymocytes and thymic stromal cells and 
the transduction mechanisms involved in thymocyte PCD. 
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